Analysts expect Veracyte, Inc. (NASDAQ:VCYT – Get Rating) to post ($0.18) earnings per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Veracyte’s earnings, with the highest EPS estimate coming in at ($0.08) and the lowest estimate coming in at ($0.24). Veracyte posted earnings of ($0.13) per share during […]
Analysts expect that Veracyte, Inc. (NASDAQ:VCYT – Get Rating) will report sales of $61.98 million for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Veracyte’s earnings. The lowest sales estimate is $60.60 million and the highest is $63.73 million. Veracyte posted sales of $36.70 million in the same quarter last […]
Analysts expect Veracyte, Inc. (NASDAQ:VCYT – Get Rating) to announce sales of $61.98 million for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Veracyte’s earnings. The lowest sales estimate is $60.60 million and the highest is $63.73 million. Veracyte reported sales of $36.70 million during the same quarter last […]
Calamos Advisors LLC acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Get Rating) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 21,475 shares of the biotechnology company’s stock, valued at approximately $884,000. Several other hedge funds have also recently made changes to their […]
Veracyte, Inc. (NASDAQ:VCYT – Get Rating)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $29.52, but opened at $26.35. Veracyte shares last traded at $26.19, with a volume of 60,662 shares traded. A number of research firms have recently commented on VCYT. StockNews.com began coverage on […]